CSPC Pharmaceutical Group (simplified Chinese: 石药集团有限公司; traditional Chinese: 石藥集團有限公司; pinyin: Shíyào jítuán yǒuxiàn gōngsī) (China Pharma, SEHK: 1093, Hang Seng Index component) researches, develops, manufactures and sells pharmaceutical products.
API products include penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine.
Formulations include antibiotics, butylphthalide (NBP) and analgesics, in addition to nearly 1,000 other products.
Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises.
CSPC Pharma is recognized as one of China's “500 Most Valuable Chinese Brands” and “Top 500 Chinese Enterprises.” In 2007, CSPC Pharma ranked second among China's top 100 pharmaceutical industry companies.